Seeking Alpha

Acadia Pharmaceuticals (ACAD +1.3%) says it receiving funding from Fast Forward, LLC, a...

Acadia Pharmaceuticals (ACAD +1.3%) says it receiving funding from Fast Forward, LLC, a not-for-profit organization established by the National Multiple Sclerosis Society, and EMD Serono, a subsidiary of Merck KGaA (MCGAY.PK). The funding will go to support R&D directed at using AC-186, ACAD’s estrogen receptor (ER)-beta agonist, as a new approach to the treatment of multiple sclerosis.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs